Maximizing neotissue growth kinetics in a perfusion bioreactor: An in silico strategy using model reduction and Bayesian optimization

Citations Over TimeTop 15% of 2017 papers

Abstract

In regenerative medicine, computer models describing bioreactor processes can assist in designing optimal process conditions leading to robust and economically viable products. In this study, we started from a (3D) mechanistic model describing the growth of neotissue, comprised of cells, and extracellular matrix, in a perfusion bioreactor set-up influenced by the scaffold geometry, flow-induced shear stress, and a number of metabolic factors. Subsequently, we applied model reduction by reformulating the problem from a set of partial differential equations into a set of ordinary differential equations. Comparing the reduced model results to the mechanistic model results and to dedicated experimental results assesses the reduction step quality. The obtained homogenized model is 105 fold faster than the 3D version, allowing the application of rigorous optimization techniques. Bayesian optimization was applied to find the medium refreshment regime in terms of frequency and percentage of medium replaced that would maximize neotissue growth kinetics during 21 days of culture. The simulation results indicated that maximum neotissue growth will occur for a high frequency and medium replacement percentage, a finding that is corroborated by reports in the literature. This study demonstrates an in silico strategy for bioprocess optimization paying particular attention to the reduction of the associated computational cost.

Related Papers

• → Large-Scale Evaluation of In Silico Gene Deletions in Saccharomyces cerevisiae(2003)140 cited
• → Monoclonal antibody production: viability improvement of RC1 hybridoma cell in different types of bioreactor(2008)5 cited
• → Μέθοδοι βιοπληροφορικής, υπολογιστικής συστημικής βιολογίας και μηχανικής μάθησης, εφαρμοσμένες στην in silico ογκολογία(2018)
• → IN SILICO ДОСЛІДЖЕННЯ МОЖЛИВИХ ШЛЯХІВ МЕТАБОЛІЗМУ АТРИСТАМІНУ В ОРГАНІЗМІ ЛЮДИНИ(2019)
• → МУЛЬТИПЛИКАТИВНАЯ ФУНКЦИЯ ПРИНАДЛЕЖНОСТИ КАК МЕТРИКА ОЦЕНКИ IN SILICO КАРДИОТОКСИЧНОСТИ ХИМИЧЕСКИХ СОЕДИНЕНИЙ(2020)